AMGEN or formerly known as Applied Molecular Genetics, is the largest biotechnological firm in the world. Robert Bradway serves as the Chairman, CEO, and President of the said company and Madhu Balachandran is the Vice President. The headquarters are found in California.
In 1980, it was founded wherein it resembled a Californian-type start-up which is common through a computer industry. As an emerging company, it was driven by a strong determination and versatility when it comes to coping with enough resources. Before, the office of CEO is simply built on a trailer in order to maximize the laboratory’s space. The scientists were just seated on a lab bench. The employees just have their bikes as a means of transportation for work. They used to work late to tackle essential concerns within the company.
At early times, Amgen stock is centered on the DNA technology. The production of insulin was considered as a success from innovations. Aside from attaining achievements, the firm also experienced how it feels to have sudden losses. However, there were still sources of income from other companies which gave rise to their research.
Amgen is a company which manufactures, discovers, develops, and markets useful medicines for various illnesses. It also concentrates on producing novel medicines which are advanced in molecular and cellular biology.
Amgen Stock Profile
Individual stakeholders – 51.11%
Mutual fund – 0.64 %
Other institutions – 32.18 %
Specifically, these are the shareholders behind Amgen stock:
The Peers and Competitors of Amgen are:
• BIIB Biogen
• GILD Sciences
• BAX Baxter International, Inc
Other executives involved on improving Amgen stock:
David W. Meline – Vice President and Chief Financial Officer
Sean E. Harper – Vice President for the Research and Development
Diana L. McKenzie – Senior Vice President and Chief Information Officer
The marketed products which contribute to an excellent Amgen stock includes:
The company’s discovered products were proven effective and very helpful for serious diseases. AMGEN is widely-recognized in 75 countries around the world. Similarly, it successfully helped millions of patients on their fight against bone disease, kidney disease, cancer, arthritis, and other illnesses. Those medicines have improved the lives of every person. Amgen stock continues to grow as they extend exceptional services.
AMGEN Stock: Manufacturing
AMGEN is proud to say that it is engaged in world- class manufacturing where the medicines undergo careful and detailed process. Each worker on the company is knowledgeable and credible when it comes to the safe manufacturing procedures. Consequently, AMGEN acquired a good reputation through its outstanding record on releasing high quality medicines.
This 2015, Amgen will be on its 35th year of serving the patients. The company’s ability to stand amidst market challenges make it more competent and excellent among other competitors. The workers within the biotechnology industry are very passionate on helping the people. They want to create a change to each patient’s lives through giving a strong hope for recovery. This should be good for Amgen stock.
My father was a chemist and a boss dyer at a woolen mill. He was a good provider for his family and was very frugal. He had been a prisoner of war in Germany in world war II and had walked the death March across Germany for six months. He knew what it was like to starve. After working for about 20 years he had enough savings to invest in stocks. Unfortunately for him other investors seemed to accumulate investable funds at the same time and the stock market was high. This was in the time period of 1967 to 1968. His stockbroker recommended stocks like Westinghouse and other companies that the brokerage firm was underwriting. My dad lost money on all of them.
My dad read a book entitled, ” How To Make The Stock Market Make Money For You”, by Ted Warren. Ted had never earned more than $200 per week, but had made a great deal of money in the stock market. The book was basically a primer on long term technical analysis. My dad did much better after reading this book and he taught its principals to me.
In 1969, I graduated from college and became a stockbroker with Bache & Co. Bache & Co sent me to New York for a six month’s training program at NYU. I tried to share the research that was given to me with friends and had disastrous results. The stock market had peaked in 1968 and did not bottom until 1974 at about 570 on the Dow Jones Industrial Average. Luckily for me I used Ted Warren’s basic methodology and was able to buy stocks at value prices which over time worked out very well. Other brokers working with me fared very poorly over this period.
In 1973, Burton Makriel authored, ” A Random Walk Down Wall Street “. The basic message was that stock prices move in a random fashion and that analysts and fund managers offered little value to investors. It wasn’t until 1976 after continuing to do very well for my clients I decided to research the logic of my approach. I was working with Ray Hanson Jr. at Barclay Douglas & Co in Providence R.I. I convinced him to work with me on this project.
The Research Project
At the time there was no data base of stock history that could be gathered by computer that was accessible to us. We found a chart book publisher with an unbroken history of chart books beginning in 1936. The chart book publisher had some of the books on hand, but we had to go to Putnam Funds, Fidelity Funds and other management companies to get the missing books. We knew the basic concept was to find good stocks that had fallen out of favor and traded for an extended period in a base without making a new low. We had to look at thousands of these charts to determine our two basic rules. We had two concerns. Number one, if we bought these stocks too early our gains would be inhibited by the length of time the stock remained stagnant in the base. Number two, some of these companies failed early in the base period. After many hundreds of hours of perusing many thousands of stocks we empirically determined or two basic rules.
Our study, published in 1978 proved that stocks do follow a discernible pattern that can be recognized and exploited. You may view the results by Googling,” Eleven Quarter Stocks “, an independent website. The recommendations at the end of the book also had average gains of over 466%. Thus from a data standpoint the proof is certainly enough to refute the classic, ” A Random Walk Down Wall Street “. Also data from 1978 to present shows that the patterns still are working.
HOW CAN THIS KNOWLEDGE HELP YOU MANAGE YOUR MONEY BETTER?
I would caution you not to be deceived by the simplicity of the rules of this concept. While they may appear obvious once they have been pointed out to you, this in no way alters their value. It is easy to understand and difficult to execute. Why? Because the rules are consistent and human emotions are not. It is people who have to act on their knowledge of these rules, and people are swayed by powerful tides of fear, greed, and impatience.
I have used this logic in working with thousands of people. Most will quit because it takes a long term patient perspective. Often when the indexes are rising these stocks are not. After waiting two years with no profit, your stock rises 50% only to drop back where it was previously. Some stocks have very big rises and entice you to buy more only to drop substantially. My way of dealing with these issues is to invest only about 10% in a group of these stocks, especially after a cyclical market decline. It is much easier to hold if you do not over invest. Your knowledge of cycles will help you in mutual fund investing as well. Take very little risk after the markets have risen for three years without big corrections and buy more aggressive assets after a four year cycle bottom. I have used this knowledge to advantage except when I make a great deal of money, I have lost a couple of times by investing too heavily in biotech stocks at too high prices. Unfortunately I have human frailty’s too.
I intend to sell the study, “Non Random Profits” as an eBook along with the rest of the story.
One of the things a new trader learns within a few weeks or so of beginning his new adventure into the world of day trading is the difference between three symbol stocks and four symbol stocks.
The first thing to be learned, with a few exceptions, is that three symbol stocks are listed on the NYSE (New York Stock Exchange) or the AMEX (American Stock Exchange), while the four symbol stocks are listed on the NASDAQ (National Association of Securities Dealers Automatic Quotation System). You can read more about the three different exchanges and how they operate by visiting their individual web sites.
Next, the new trader usually learns that most day traders prefer to trade NASDAQ stocks over “listed”, a term that usually refers to AMEX and NYSE stocks but not NASAQ stocks.
The reason is quite simple. Historically, the root of it goes back to the hay days of day trading in the pre year 2000 bubble days. Most of the fast moving stocks were NASDAQ stocks. This is where the largest percentage of the high tech wonders were traded. It was then, and is today, where most of the day trading action is.
A lot of tools were developed or made available to day traders for the first time, and many of them were based on trading NASDAQ stocks.
However, along with that action comes a much higher degree of risk. NASDAQ stocks are much more likely to give you huge moves up and down with tremendous spurts of volume, making them much more risky. Of course, with that higher risk also comes the potential of higher profits…or larger… much larger losses than slower, more orderly moving stocks.
That’s why I like three symbol stocks.
As a general rule they will move in a much more orderly fashion. You are less likely to get whip lashed all over the street on listed stocks. They usually move much more slowly, making it easier to read the potential move via such tools as Level2 and Stochastic charts.
However, even three symbol stocks with the right news or set of events can trade in huge volume, causing wide swings and added risks. Yet, as a general rule they will trade somewhat boring compared to their cousins on the NASDAQ.
Normal everyday events like analyst upgrade and downgrades usually do not send the average NYSE or AMEX listed stock into a mania move. Instead they will trade in a more orderly pattern. Depending on the news they will often slowly tick up or down, very often taking thirty minutes, an hour or even more to get a decent profit. They often make a number of stop and goes, minor pullbacks, but they usually do not make the drastic pullbacks that NASDAQ stocks so often do. In Daytraders.com I refer to that as a pop’n flop.
I find both Level 2 and Stochastics charts much easier to use in predicting their behavior. (See: Tools of the Trader at http://www.TraderAide.com and other information on Level 2 and Stochastics if you are not familiar with these terms.
Keep in mind I am talking in general terms here. Certain three symbols, NYSE or AMEX stocks, can trade every bit as radically as any stock on any exchange. There are few that have a huge day trader following and can be sent into a frenzy if the right news hits the tape.
Some these “high flyers” come out the high tech sector, which includes the Internet stocks and semiconductors. Other “high flyers” come from the biotech stocks, which have increased volatility from such news as FDA approvals. After a while you will recognize the symbols because there are fewer of them than on the NASDAQ that trade like a house on fire on the right news.
Give them a try and see if you don’t lower you blood pressure just a bit!
No permission is needed to reproduce an unedited copy of this article as long the About The Author tag is left in tact and hot links included. Questions and comments can be sent to: floyd@TraderAide.com.
Floyd Snyder has been trading and investing in the stock market for three decades. He was on the forefront of the day trading craze that swept the nation back in the late 1990’s, both as a trader and as the moderator of one of the Internet’s largest real time trading rooms, [http://Daytraders.com] He is the owner of [http://www.TraderAide.com] and Strictly Business Magazine at [http://www.sbmag.org]
Alternative Ways to Participate in the Stock Market
Options for Trading in the Stock Market
There are more mutual funds available today than there are stocks, and a tremendous industry surrounding them that provides research, facilitates meetings, sells software, hosts seminars, employs spokesmodels, and in general focuses on picking and buying the right stocks. The fundamental assumption is that the stock market goes up over time and will reward long-term investors with a return that will meet their financial goals. But this view has not always been the case. Prior to 1980, the stock market was considered by many to be too risky for retirement savings, and this didn’t really change until the creation of 401(k) plans in 1981 and the subsequent explosion of mutual funds. Investors in the 80s and 90s then experienced a market that delivered an average annual return of 13% or more, and throwing darts at the business section of the local newspaper was as good a technique as any for picking stocks. The predominant strategy that came out of this time was to buy stocks or mutual funds, and hang on through the dips. Any other strategy in the 80s and 90s ultimately resulted in lower returns.
If you believe strongly that the stock market will always go higher and will do so within your investment timeframe, then a “buy stocks and hold on” strategy is consistent with your beliefs, but that’s not the only strategy available. If you have doubts about what stocks will do over the next 10 years or so (as I do), then it would be prudent to understand the other methods that are available for being involved in
What is Biotechnology?
the stock market. The stock market has been volatile but ultimately flat for about 13 years at the time of this writing, so we’ve already lost more than a decade of the 10% annual returns the stock market is supposed to provide, and from all indications it would seem that volatility will be around for a long time. With interest rates at all-time lows, bonds and bond funds are not the safe havens they used to be, so I still think stocks are the best vehicle for achieving inflation-beating returns. However, making money in stocks is going to take a little more work than simply buying stocks and hanging on for the ride.
Making Money When Stocks Go Down
If you firmly believe that the global economy is in a death spiral and you’re ready to buy bottled water and find a cave to live in, then shorting stocks is the most consistent strategy with your belief system. Shorting a stock involves selling a stock you don’t own (i.e. borrowing it from your broker for a while), with the intent of purchasing it back later at a lower price. If you’re right, this strategy can make you look brilliant at dinner parties because you will be making money while everyone else is losing money. However, if you’re wrong, you will need to diligently avoid any financial conversations. Investment advisors who aren’t afraid of risking other people’s money will sometimes feel so strongly about the direction of the market that they will make a big bet on the short side of the market. Those who are successful end up with their own radio shows. Those who are a little off on their timing end up with clients who are losing money while everyone else is making money. In a short amount of time, these advisors are asking “would you like fries with that.”
Warren Buffett’s famous rules of investing are “Rule No. 1: Never lose money. Rule No. 2: Never forget Rule No. 1.” Accepting unlimited losses in the hope that stocks will come back violates both of these rules. As a general rule, limiting losses requires giving up some amount of upside potential. One way to accomplish this is to insure your stocks using Put options. Put options establish an absolute floor on potential losses at the expense of the premium paid for the options. Although there are several techniques that can help recover some or all of the cost of the “Put insurance,” if the stock price does not fall before the option expires, the cost of the Put option is lost. This is similar to losing the premium on your homeowner’s insurance if your house doesn’t burn down. Most people have accepted the tradeoff and are not disappointed when they don’t end up using their fire insurance. The belief that is consistent with a “limited loss” strategy is that stocks will go up, but that large losses are unacceptable.
The final method I’ll cover is for investors more interested in meeting financial goals than in keeping up with the market. Similar to a Limited Loss strategy, a Direction-Neutral strategy (or, more accurately, delta-neutral) involves giving up a little more upside potential in return for an equal chance to profit when a stock moves down. This strategy profits from stock volatility in either direction instead of only when a stock goes up. From a very high level, think of this strategic objective as capturing some of the upside when a stock goes up (say, 5% if a stock goes up 10%), and capturing some more upside when a stock goes down (another 2.5% if the stock pulls back 5%). With this technique, the risk is no longer that a stock price might drop, but rather that a stock price stays the same with very little volatility.
Since Direction-Neutral is probably less familiar to most people than other strategies, it merits a little more detail. It should be noted that “Direction-Neutral”, or “delta neutral,” is different than the typical strategy used in a long-short or market-neutral mutual fund. The typical fund categorized as long-short or market-neutral uses a combination of owning stocks that are expected to go up and shorting stocks that are expected to go down. The problem is that this raises the possibility of being wrong on both sides. A delta neutral position uses a combination of stocks and options so that the only amount of capital at risk is the cost of the options. If the stock price does not move, the value of the options will gradually decay similar to the Limited Loss strategy. So the trick is to pick a stock that moves. Microsoft is probably not a good candidate for a delta neutral strategy, but Google or Apple would be. Similarly, Johnson & Johnson is probably not a good healthcare holding, but a volatile biotech stock would be interesting. In general, it is easier to pick a stock that has a good chance of price movement in the future (just look at the last several earnings cycles) than trying to pick a stock that will consistently go up in the future.
Another requirement for a successful direction-neutral strategy is the ability to lock in gains and readjust the position. If the stock price moves up or down after a neutral position is established, the position is no longer neutral. If the position has met a performance goal, or if the underlying stock shows signs that it may be done moving, it is important to lock in the gain and readjust the position back to neutral. This requires work that goes well beyond buying a stock and chanting “I will not sell, I will not sell,… ” Diligently watching the performance of direction-neutral positions and managing them appropriately allows profits to be captured on moves in one direction and additional profits if the stock bounces are pulls back.
Below is a summary of the four basic techniques for investing in stocks, along with the belief about the stock market that would be consistent with each technique.
Technique:Buy stocks (or mutual funds) and hold on.
Primary Risk:Stocks may go down
Belief: “Stocks will go up fast enough to meet my financial goals regardless of short-term losses.”
Technique:Short stocks (or buy inverse funds or bear market funds)
Primary Risk:Stocks may go up
Belief:”Global conditions are deteriorating and the market is in trouble.”
Primary Risk:Stocks go down or stay the same, but risk is limited
Belief:”I think stocks will go up over time, but I can’t or won’t accept large losses.”
Primary Risk:Lack of volatility
Belief:”I’m not sure which direction stocks will go, but I’m pretty sure they’ll go somewhere.”
Jerry Verseput is a Certified Financial Planner and President of Veripax Financial Management, LLC in Folsom, CA. For more information about Veripax Financial Management’s services and Mr. Verseput’s portfolio management philosophy and techniques, visit http://www.veripax.net
Day Trading Stocks – Two Must-Have Skills For You to Master!
In day trading stocks, you need to learn two very important skills. The first and the easy one is doing the right stock picking. The second is the most important and the difficult one. How to trade these stocks? What I mean by how to trade these stocks is the right entry and the right exit. Without this, you will never succeed at your day trading endeavor.
Finding good stocks for day trading is not difficult with more than 50,000 stocks listed in the US Stock Markets. The most important rule to remember is that you are not an investor. Rather you are a day trader who does not hold positions overnight. No need to think long term. Keeping this fact at the back of your mind, you should focus on the intraday price movements of your chosen stocks.
There are some rules that you need to follow when doing the stock picking. These rules have been developed by different successful day traders with experience. The first rule that narrows down the universe of stocks that you can choose says that only choose those stocks that have a daily average volume of one million shares or more. What this means is that the stock is having an average daily volume of around one million stocks daily for the last many weeks and months rather than having this traidng volume for one odd day.
This rule should be followed religiously by you in doing the stock picking for day trading. You should try to avoid low priced stocks with high volume as well as high priced stocks with low volume. I explain it more in the next paragraph.
Once you have narrowed down the universe of stocks that you can choose for doing day trading, now you need to narrow it down further with this rule. This rule says that choose stocks that are trading btween $10 and $100 per share. Now, a price below $10 just,means that the stock is not well known and there might be some problems with the company. However, a price of above $10 per share gives an indication that the company has good health and the stock is not having severe liquidity problems. You see, liquidity in the stock that you choose is very important. To ensure, liquidity you chose only those stocks that were trading on average with a volume of one million shares.
Stocks above $100 might be overpriced and can be highly volatile with wide retracing swings. Stocks between the range of $10 to $100 have a consistent intraday price patterns and are best suited for day trading. When you pick a stock in this price range, observe its intraday price swing. Study the past three days data and observe the intraday chart patterns to see the price bouncing back and forth between the intraday support and resistance levels. You want a stock that has a good intraday swing.
Don’t trade stocks that are affected by government regulations. For example, a pharmaceutical stock or a biotech stock may not be good. Suppose, an approval is pending with FDA! You are trading that stock when FDA announces more tests are needed before giving the approval. You can imagine what can happen. In the same light, stay away from day trading stocks of companies that are in the process of merging.
Forex day trading can be a much better option for you as compared to day trading stocks if you are really serious in day trading. Currency market is huge with around $3.2 trillion transacted in it daily. Combine all the stock markets in the world and they don’t add up to even one trillion dollar. Currency market is open 24/5 unlike the stock market. So you can trade currency at a time that best suits you. There are six major currency pairs that make up more than 90% of the business transaction in the currency market as compared to thousands of stocks in the stock market that require a lot of fundamental and technical research. By trading only two of these major currency pairs, you can make a lot of money. Give forex day trading a try. It is a better option!
Mr. Ahmad Hassam has done Masters from Harvard. Give 60 days RISK FREE trial to this Flexible Forex Day Trading course by Bill Poulos that teaches trading not more than 20 minutes each day and making 5 figures. Learn this 10 minute a day highly profitable Swing Trading Strategy that works for stocks, forex and futures!
These days, the future of the stock market hangs in the balance. One day it’s up, the next it’s down; today we’re recovering, and tomorrow we’ll be doomed again. This happens any time the market moves essentially sideways for any period of time. Right now is a great time to weed out under performers from your portfolio, while possibly adding some fresh investments. One interesting place to look to investing right now is Biotech ETFs.
Biotech stocks are well known for their volatility. It is due to this volatility that some traders and investors may focus exclusively on this sector, while others will avoid it all together. The thing about biotech in general is that as technologies advance, which they always will, it continues to have new places to grow into. It is one of the more certain growth sectors because whatever the economy is doing, new biotech advances are being made, and being sold.
It can be quite difficult and time consuming to pick out the specific winners within this sector. A company can seem to be doing fine one month, and completely crash and burn by the end of the year because they’ve put too much money into the research and development of a project that never came to fruition. This is where investing in Biotech ETFs comes into play.
Biotech ETFs allow you to easily diversify your risk without having to do the incredible amount of grunt work involved in uncovering solid biotech companies. There are several that are doing quite well right now, and are bucking the general trend of the marketplace because they’ve managed to research and spread their holdings to the right companies.
Your best bet is to find a list of the Biotech ETFs, there are less than 10 of them, and from there try to find the best biotech ETF to add to your portfolio. This way, you are essentially piggy-backing on their research, and your research can be focused on discovering whether or not they know how to invest wisely.
Learn more about Biotech ETFs at my website about trading and investing – Adapt or Perish
America’s population is getting older and demanding more medication and procedures to keep them in good health. That makes biotech companies particularly attractive to investors. Not only do these companies provide potential employment opportunities for many, they also may offer the investor an opportunity to offset some of the losses experienced in other sectors. For those investing in their future by seeking careers in biotech, the area also provides ample opportunity for growth and solid employment.
Buying stock or seeking jobs in this area both require vigilance in selecting the right company. In many ways, job or career seeking individuals look for the same stability and financial strength as investors. Both groups depend on the company sustaining growth and remaining strong even during tough economic times so selecting the right company becomes imperative for both groups of people.
According to a recently published report by Ernst & Young, LLP called “Focus on Fundamentals: The Biotechnology Report,” The companies involved in the biotechnology sector provide greater security to both the job seeker and investor because of their investment in not only the research and development of new products but also their investment in their future by retaining secure capital reserves.
Company philosophy, sales growth, profitability, trading stability, level of debt and employee performance among other factors, all play an important role in the company’s financial success. These are important factors to consider regardless of the sector, before purchasing a stock or seeking employment. Each company grows its business differently from others. Look for a company that offers potential for growth without sacrificing its profitability or financial strength.
How to Invest in Biotech Stock
Some companies, for instance, believe that bigger is better regardless of financial situations. During hard economic times, maintaining a company with a high level of debt often calls for layoffs, thus creating investor concern and lower stock prices. It should also be of concern for those seeking a career. If the company has to cut back employees, your job may be on the line at a time where other employment is difficult to find.
While a Large Biotech Company is a sign of prestige to both investor and those seeking careers, smaller companies may offer big opportunities. If you find a smaller company that formed alliances with a larger more established pharmaceutical firm, you may have a bigger potential for growth in the areas of both jobs and the future growth of stock prices.
These companies caught the eye of large pharmaceutical firms that recognize marketable products. The larger company has the resources to not only do additional research on the smaller company’s product and get it to market but also know the potential for sales of the product. Those seeking careers with this type of smaller company should look into the potential of stock purchase programs as part of the company’s financial package.
Strong fundamentals, a good pipeline of products and a competent team at the helm of the company offer the investor and those seeking careers an abundant opportunity for a secure and prosperous future. As the American public ages, more and more demand creates an ever-growing need for the products produced by those in the biotech sector. This does not mean that the investor should stop using fiscally sound practices of diversification, quite the contrary. However, it does mean that the well-informed investor should include biotech stocks in their portfolio to boost their returns. Selecting the best companies in that sector will make a difference for fiscal future of both the job seeker and investor.
Matinez Betheliza – Ph.D. – Organizational Psychology. Provides you with a deep level of insight into your career direction and career development.
Biotechnology is an advancing area of business at the moment. It involves living microorganisms that are used in conjunction with technological processes to create new products in a variety of ways.
Since this is an advancing technology it is not surprising that a lot of companies involved in this area of science issue biotech penny stocks for people to buy. It is an attractive area to invest in when it comes to penny stocks too, because there is always the chance that you will come across that one company which could make the big time.
So how do you find the right biotech penny stocks to invest in?
You can start your research online, as there are plenty of websites that list some of the most promising stocks in this area. Don’t take everything for granted though – make sure you research each company and find those that have been trading stocks for a while. New companies should be watched to see what happens. You need a steady company which is performing reasonably well in order to make the most of it.
Some biotech companies do well for a short period of time and grab the headlines before fading into obscurity again. If you invest in one of these you will surely lose your money. So stand back and get to know the market and the players before investing anything in biotech stocks.
Don’t discount the websites that give you the names of biotech companies however. Names such as Aastrom Biosciences Inc, Magnum D’Or Resources and Opexa Therapeutics can all be found on such sites. Read what they have to say and then do your own research to get the low down on whether a particular stock might be worth investing in.
It goes without saying that doing some general research into penny stocks will also be useful. Learning how the land lies will highlight potential dangers and worthwhile investments as you discover where your money will be most at home.
Even when you do make your first investment be sure to keep an eye on it. Some investors recommend that only a small percentage of your investments should be ploughed into biotech penny stocks. Always spread the risk as much as you can, watch for new companies and new opportunities and don’t be afraid to bail out if a biotech company looks to be going downhill.
BioTech Breakout Trader Mark Messier Isn’t Your Typical Trader
Trading Biotech Stocks
Trading Biotechs is definitely not an easy thing to do. For one, you can be very right or vey wrong at some point after you have actually purchased a biotech stock. It is important for investors to understand that they should invest their money to tolerate the volatile market of the biotech sector. Moreover, investors should also have the tenacity for long term investment. These are probably the reasons why biotech stocks trading is not for the weak-hearted.
On the other hand, there is a wide range of unique advantages of the biotech sector. The combination of scientific and technological advances is one of the opportunities that biotech trading offers. Additionally, the demographic changes in the society that cause an increase in medical care are another glaring opportunity as well. Thus, despite the challenges that biotech stock trading may pose, many investors are still enticed into this investment scheme.
However with the proper tools, stocks trading in biotech is not that difficult at all, most especially with Mark Messier’s BioTech Breakout Trader. This biotech stocks trading community includes real time posting of trades including the entry and exits points. Members of the BioTech Breakout Trader can actually participate in live interactive Webinars. Moreover, it includes forums which consist of a community of informed traders. This is definitely a plus factor not only to experienced traders but most especially to the newbies.
According to a BioTech Breakout Trader review, this program provides detailed reports on upcoming FDA and clinical trades. Important chats and technical analysis for profitable trading are provided as well. To ensure that members get a regular update on what’s happening in biotech stocks trading, a weekly newsletter is provided as well.
Members are assured of constant alerts of critical news through their emails or text messages. Since the biotech sector is a highly volatile market, members of BioTech Breakout Trader are provided with analyst reports that contain consistently updated summaries. Members can also chat in interact with one another in the Live Chat Room. With this feature, members can immediately get responses from other members in the community for some questions that they might have.
According to another BioTech Breakout Trader review, there is probably no better tool to use in biotech stocks trading. It practically covers all important aspects in biotechnology including FDA, clinical trials, Bio-Pharma, and HavRx Healthcare sub sector indexes. As such, if you intend to invest in biotech stocks, make sure you consider the information that BioTech Breakout Trader has to offer.
To Find Out More About Mark Messier and his BioTech Breakout Trader Program, visit our BioTech Breakout Trader Review and See What’s All Included in the Program and What You Can Realistically Expect From Trading With It.
Here are four myths about trading and stock market investing;
· The stock cannot fall any further.
Most people assume that if a company’s share price has fallen by a certain amount, it is highly impossible to fall any further. Share prices fall as a result of various factors. It could be that the company has reduced its growth estimate, or just that the company has fallen out of favour with analysts. The stock market is to a very large extent speculation. A falling share price could mean that there is speculation that the company might be about to experience difficult times. If a company’s share price has fallen 50%, it can still fall by a further 50%. It’s even possible for shares of historically good companies to become worthless. In the UK, Northern Rock is a very good example. In the US, Lehman Brothers is a very good example.
· The stock cannot rise any further.
Similarly a lot of people assume that because a company’s share price has tripled in value, it is very unlikely for it to rise any further. A share price can rise to a level that defies explanation. This is seen in a lot of technological and biotech stocks.
· You have to be smart to succeed.
This is also untrue. Trading is not an activity where the person with the biggest intellect wins. “The most important quality for an investor is temperament, not intellect… You need a temperament that neither derives great pleasure from being with the crowd or against the crowd.” Results in investing is best summarised by this quote by Adeola Odutola a Nigerian industrialist, “Over the years I have known too many people who are not terribly intelligent but who somehow get things done slowly and perhaps not imaginatively, but they get there. Yet too many able people who understand much better and see much more clearly and talk much clearly get nothing done. Hence, I have observed that effectiveness is neither a talent nor ability. It is a practice, a habit”
· Trading is for the fast and furious.
Even though certain timeframes, e.g. day trading requires speed and the ability to make quick decisions, trading as a whole requires a lot of patience. According to Warren Buffet, “The Stock Market is designed to transfer money from the Active to the Patient”. Seth Glickenhaus puts it in this context, “You make money on Wall Street by being very selective and being patient, waiting for those opportunities that are irresistible, where the percentages are very heavily in your favor”.
Deji Odusi has been using the stock market to generate an extra source of income for over four years. Deji shows that technical analysis works if you take time to understand the techniques, find your edge and diligently stick to your plan. He is the author of “Stock Market Blueprint for the Diligent Investor – Proven Strategies for Making Money in the Stock Market”.